Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai Diabetes Research Institute is a specialized research organization based in Yantai, China, focused on the development of innovative treatments for metabolic disorders, particularly diabetes. The institute engages in both basic and applied research to identify novel therapeutic targets and develop pharmacological interventions. Its work often involves collaborations with regional pharmaceutical companies and academic institutions to translate laboratory findings into clinical applications. The institute's primary focus remains on improving glycemic control and managing complications associated with type 2 diabetes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yantai Diabetes Research Institute.